• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

NICE Medical Technologies Guidance: a novel and rigorous methodology to address a new health technology assessment challenge.

作者信息

Campbell Bruce, Campbell Mark

机构信息

Medical Technologies Advisory Committee, National Institute for Health and Clinical Excellence, Manchester, UK.

出版信息

Appl Health Econ Health Policy. 2012 Sep 1;10(5):295-7. doi: 10.2165/11640550-000000000-00000.

DOI:10.2165/11640550-000000000-00000
PMID:22909081
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3713955/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4f8/3713955/ed816206aef6/40258_2012_1863_Tab1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4f8/3713955/ed816206aef6/40258_2012_1863_Tab1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4f8/3713955/ed816206aef6/40258_2012_1863_Tab1.jpg

相似文献

1
NICE Medical Technologies Guidance: a novel and rigorous methodology to address a new health technology assessment challenge.英国国家卫生与临床优化研究所医疗技术指南：应对新型卫生技术评估挑战的一种新颖且严谨的方法。
Appl Health Econ Health Policy. 2012 Sep 1;10(5):295-7. doi: 10.2165/11640550-000000000-00000.
2
PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites: a NICE Medical Technology Guidance.PleurX 腹腔导管引流系统，用于治疗抵抗性、复发性恶性腹水的真空辅助引流：NICE 医疗技术指南。
Appl Health Econ Health Policy. 2012 Sep 1;10(5):299-308. doi: 10.1007/BF03261864.
3
[Therapy refractory ascites: insertion of a tunneled long-term peritoneal catheter].[治疗难治性腹水：置入带隧道的长期腹膜导管]
Dtsch Med Wochenschr. 2009 Oct;134(41):2073-6. doi: 10.1055/s-0029-1237558. Epub 2009 Oct 2.
4
Pleurx tunneled catheter in the management of malignant ascites.Pleurx隧道式导管在恶性腹水治疗中的应用
J Vasc Interv Radiol. 2001 Mar;12(3):373-5. doi: 10.1016/s1051-0443(07)61919-8.
5
Permanent indwelling peritoneal access device for the management of malignant ascites.用于治疗恶性腹水的永久性留置腹膜通路装置
Cardiovasc Intervent Radiol. 1994 Sep-Oct;17(5):292-4. doi: 10.1007/BF00192454.
6
Intractable malignant ascites: an alternative management option.难治性恶性腹水：一种可供选择的治疗方法。
J Palliat Med. 2011 Feb;14(2):251-3. doi: 10.1089/jpm.2010.0196.
7
[Permanent tunneled drainage for malignant ascites: initial experience with the PleurX® catheter].[恶性腹水的永久性隧道式引流：PleurX®导管的初步经验]
Radiologia. 2010 Nov-Dec;52(6):541-5. doi: 10.1016/j.rx.2010.06.005. Epub 2010 Sep 21.
8
Peritoneal-urinary drainage for treatment of refractory ascites: a pilot study.腹膜-尿液引流治疗难治性腹水：一项试点研究。
J Vasc Interv Radiol. 1998 Nov-Dec;9(6):998-1005. doi: 10.1016/s1051-0443(98)70440-3.
9
Delayed benign massive pneumoperitoneum associated with tunneled peritoneal drainage catheter placement.与隧道式腹膜引流导管置入相关的迟发性良性大量气腹。
J Vasc Interv Radiol. 2015 Jun;26(6):925-7. doi: 10.1016/j.jvir.2015.02.012.
10
Use of a LeVeen shunt as a percutaneously placed abdominal drainage catheter for malignant ascites.使用LeVeen分流管作为经皮放置的用于恶性腹水的腹腔引流导管。
J Vasc Interv Radiol. 1995 Mar-Apr;6(2):253-4. doi: 10.1016/s1051-0443(95)71108-3.

引用本文的文献

1
Assessment of medical device features in health technology assessment: a review of NICE medical technology guidance.健康技术评估中医疗设备特征的评估：对英国国家卫生与临床优化研究所医疗技术指南的综述
Int J Technol Assess Health Care. 2025 Jul 29;41(1):e60. doi: 10.1017/S026646232510041X.
2
GaitSmart Rehabilitation Exercise Programme for Gait and Mobility Issues: A NICE Medical Technologies Guidance.针对步态和行动问题的GaitSmart康复锻炼计划：英国国家卫生与临床优化研究所医疗技术指南
Appl Health Econ Health Policy. 2025 Mar 10. doi: 10.1007/s40258-025-00955-y.
3
Sedaconda ACD-S for Sedation with Volatile Anaesthetics in Intensive Care: A NICE Medical Technologies Guidance.

本文引用的文献

1
PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites: a NICE Medical Technology Guidance.PleurX 腹腔导管引流系统，用于治疗抵抗性、复发性恶性腹水的真空辅助引流：NICE 医疗技术指南。
Appl Health Econ Health Policy. 2012 Sep 1;10(5):299-308. doi: 10.1007/BF03261864.
Sedaconda ACD-S 在重症监护中用于挥发性麻醉剂镇静：NICE 医疗技术指南。
Appl Health Econ Health Policy. 2024 Nov;22(6):805-813. doi: 10.1007/s40258-024-00903-2. Epub 2024 Jul 26.
4
Health technology assessment - an important opportunity to inform the use of medical devices in the paediatric population: an analysis of NICE Medical Technology Guidance.卫生技术评估——为儿科人群医疗器械使用提供信息的重要契机：对英国国家卫生与临床优化研究所医疗技术指南的分析
Appl Health Econ Health Policy. 2023 Jul;21(4):533-535. doi: 10.1007/s40258-023-00805-9. Epub 2023 May 6.
5
Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance.Axonics 骶神经调节系统治疗难治性膀胱过度活动症：NICE 医疗技术指南。
Appl Health Econ Health Policy. 2022 May;20(3):305-313. doi: 10.1007/s40258-021-00701-0. Epub 2021 Dec 29.
6
gammaCore for Cluster Headaches: A NICE Medical Technologies Guidance.用于丛集性头痛的伽马刀：英国国家卫生与临床优化研究所医疗技术指南
Pharmacoecon Open. 2021 Dec;5(4):577-586. doi: 10.1007/s41669-021-00276-5. Epub 2021 Jul 28.
7
Thopaz+ Portable Digital System for Managing Chest Drains: A NICE Medical Technology Guidance.托帕兹便携式胸腔引流管理数字系统：NICE 医疗技术指导
Appl Health Econ Health Policy. 2019 Jun;17(3):285-294. doi: 10.1007/s40258-019-00461-y.
8
Peristeen Transanal Irrigation System to Manage Bowel Dysfunction: A NICE Medical Technology Guidance.经肛门灌洗系统治疗肠功能障碍：NICE 医疗技术指导
Appl Health Econ Health Policy. 2019 Feb;17(1):25-34. doi: 10.1007/s40258-018-0447-x.
9
The Memokath-051 Stent for the Treatment of Ureteric Obstruction: A NICE Medical Technology Guidance.Memokath-051 支架治疗输尿管梗阻：NICE 医疗技术指导
Appl Health Econ Health Policy. 2018 Aug;16(4):445-464. doi: 10.1007/s40258-018-0389-3.
10
ENDURALIFE-Powered Cardiac Resynchronisation Therapy Defibrillator Devices for Treating Heart Failure: A NICE Medical Technology Guidance.ENDURALIFE 动力心脏再同步治疗除颤器设备治疗心力衰竭：NICE 医疗技术指导。
Appl Health Econ Health Policy. 2018 Apr;16(2):177-186. doi: 10.1007/s40258-017-0354-6.